Chardan Healthcare Acquisition 2 Corp. announced that it closed its initial public offering of 8,500,000 units at $10.00 per unit. The underwriters have been granted a 45-day option to purchase up to an additional 1,275,000 units offered by the Company to cover over-allotments, if any. Chardan acted as sole book running manager in the offering.
The units began trading on the NYSE American under the ticker symbol “CHAQ.U” beginning April 24, 2020. Each unit consists of one share of common stock and one warrant to purchase one-half of one share of common stock at an exercise price of $11.50 per whole share. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be listed on the NYSE under the symbols “CHAQ” and “CHAQ.WS” respectively.
Chardan Healthcare Acquisition 2 Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although the Company intends to focus its search on a target businesses operating in North America in the health care industry.
This was reported by PR Newswire on April 23, 2020.
Contact information: Jonas Grossman, President and Chief Executive Officer, Chardan Healthcare Acquisition 2 Corp., 17 State Street, 21st Floor, New York, New York 10004; 646-465-9000